METHYL 2-(3-BROMO-4-(METHOXYMETHOXY)PHENYL)ACETATE, 95.0%, 250mg

1-(3-phenylpropyl)-1,4-diazepane bis(4-methylbenzenesulfonate), 95.0%, 25g

4-(Benzyloxy)-3-chloro-5-fluorobenzaldehyde, 95%, 500mg

(S)-(-)-Trityl glycidyl ether, 95.0%, 10g

Methyl 2,3-dimethylbenzoate, 97.0%, 100g

Perossido di idrogeno, 50% tecnico, stab., 10 l, confezione plastica.

4-(Difluoromethyl)benzene-1-sulfonyl chloride, 95%, 1g

Ethyl 4,5,6,7-tetrahydrobenzo[d]isoxazole-3-carboxylate, 95+%, 250mg

Simbolo di avvertenza secondo ISO 7010 Etichetta individuale, Pericolo dovuto alle batterie, Lunghezza laterale 100 mm, 1 pezzo

N-Methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine, 95.0%, 5g

Acid-PEG4-S-S-PEG4-acid, 100mg

3-(2-chlorophenyl)-6-(piperazin-1-yl)pyridazine, 95.0%, 2g

(1R)-(-)-(10-Camphorsulfonyl)oxaziridine, 95.0%, 5g